| Ident. | Authors (with country if any) | Title |
|---|
| 000079 |
GUOFANG CHEN [République populaire de Chine, Australie] ; Hisatomi Arima [Australie] ; GUOJUN WU [Australie, République populaire de Chine] ; Emma Heeley [Australie] ; Candice Delcourt [Australie] ; PEIYING ZHANG [République populaire de Chine] ; Alejandro A. Rabinstein [États-Unis] ; Thompson Robinson [Royaume-Uni] ; Christian Stapf [France] ; YINING HUANG [République populaire de Chine] ; LILI SONG [Australie, République populaire de Chine] ; JIE YANG [Australie, République populaire de Chine] ; XIA WANG [Australie] ; QIANG LI [Australie] ; XIAOYING CHEN [Australie] ; John Chalmers [Australie] ; Craig Anderson [Australie] | Subarachnoid Extension of Intracerebral Hemorrhage and 90-Day Outcomes in INTERACT2 |
| 000A91 |
Pamela M. Rist [États-Unis] ; John Chalmers [Australie] ; Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Stephen Macmahon [Australie] ; Mark Woodward [Australie] ; Tobias Kurth [États-Unis, France] ; Christophe Tzourio [France] | Baseline Cognitive Function, Recurrent Stroke, and Risk of Dementia in Patients With Stroke |
| 001179 |
Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie, Royaume-Uni] ; Giuseppe Mancia [Italie] ; Marie-Germaine Bousser [France] ; Christophe Tzourio [France] ; Anthony Rodgers [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial |
| 002158 |
Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; LISHENG LIU [République populaire de Chine] ; Christophe Tzourio [France] ; Mark Woodward [États-Unis] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Anthony Rodgers [Australie] ; John Chalmers [Australie] | Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial |
| 002339 |
Sébastien Czernichow [Australie, France] ; Toshiharu Ninomiya [Australie] ; Rachel Huxley [Australie] ; André-Pascal Kengne [Australie] ; G. David Batty [Australie, Royaume-Uni] ; Diederick E. Grobbee [Pays-Bas] ; Mark Woodward [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial |
| 002461 |
Hisatomi Arima [Australie] ; Christophe Tzourio [France] ; Craig Anderson [Australie] ; Mark Woodward [États-Unis] ; Marie-Germaine Bousser [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial |
| 002768 |
Jasper J. Brugts [Pays-Bas] ; Toshiharu Ninomiya [Australie] ; Eric Boersma [Pays-Bas] ; Willem J. Remme [Pays-Bas] ; Michel Bertrand [France] ; Roberto Ferrari [Italie] ; Kim Fox [Royaume-Uni] ; Stephen Macmahon [Australie] ; John Chalmers [Australie] ; Maarten L. Simoons [Pays-Bas] | The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials |
| 002856 |
Carole Dufouil [France] ; Ophélia Godin [France] ; John Chalmers [Australie] ; Oghuzan Coskun [France] ; Stephen Macmahon [Australie] ; Nathalie Tzourio-Mazoyer [France] ; Marie-Germaine Bousser [France] ; Craig Anderson [Australie] ; Bernard Mazoyer [France] ; Christophe Tzourio [France] | Severe Cerebral White Matter Hyperintensities Predict Severe Cognitive Decline in Patients With Cerebrovascular Disease History |
| 003D31 |
John Chalmers [Australie] ; Nikola Sprigg [Royaume-Uni] ; Laura J. Gray [Royaume-Uni] ; Philip M. W. Bath [Royaume-Uni] ; Gudrun Boysen [Danemark] ; Peter Paul De Deyn [Belgique] ; Pal Friis [Norvège] ; Didier Leys [France] ; Reijo Marttila [Finlande] ; Jan-Edwin Olsson [Suède] ; Desmond O'Neill [Irlande (pays)] ; Bernd Ringelstein [Allemagne] ; Jan-Jacob Van Der Sande [Pays-Bas] ; Ewa Lindenstr M [Danemark] | Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke : data from the TAIST trial. Commentary |
| 003D54 |
Hisatomi Arima [Australie] ; Christophe Tzourio [France] ; Ken Butcher [Australie] ; Craig Anderson [Australie] ; Marie-Germaine Bousser [France] ; Kennedy R. Lees [Royaume-Uni] ; John L. Reid [Royaume-Uni] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie] ; John Chalmers [Australie] | Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial |
| 003F04 |
Hisatomi Arima [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Craig Anderson [Australie] ; Anthony Rodgers [Nouvelle-Zélande] ; Stephen Davis [Australie] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] | Lower target blood pressures are safe and effective for the prevention of recurrent stroke : the PROGRESS trial |
| 004446 |
Pierre Amarenco [France] ; Anushka Patel [France] ; Mark Woodward [France] ; Duncan J. Campbell [Australie] ; David R. Sullivan [Australie] ; Samuel Colman [France] ; John Chalmers [France] ; Bruce Neal [France] ; Stephen Macmahon [France] | Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease |
| 004640 |
Carole Dufouil [France] ; John Chalmers [Australie] ; Oguzhan Coskun [France] ; Véronique Besancon [France] ; Marie-Germaine Bousser [France] ; Pierre Guillon [France] ; Stephen Macmahon [Australie] ; Bernard Mazoyer [France] ; Bruce Neal [Australie] ; Mark Woodward [Australie] ; Nathalie Tzourio-Mazoyer [France] ; Christophe Tzourio [France, Australie] | Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke : The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) magnetic resonance imaging substudy |
| 004A11 |
Anthony Rodgers [Nouvelle-Zélande] ; Neil Chapman [Australie] ; Mark Woodward [Australie] ; Li-Sheng Liu [République populaire de Chine] ; Sam Colman [Australie] ; Arier Lee [Nouvelle-Zélande] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Francois Gueyffier [France] | Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. Commentary |
| 004D83 |
Stephen B. Harrap [Australie] ; Christophe Tzourio [France] ; Francois Cambien [France] ; Odette Poirier [France] ; Segolene Raoux [France] ; John Chalmers [Australie] ; Neil Chapman [Australie] ; Samuel Colman [Australie] ; Solenn Leguennec [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Takayoshi Ohkubo [Australie] ; Mark Woodward [Australie] | The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition |
